Found: 9
Select item for more details and to access through your institution.
Crosstalk of Histone and RNA Modifications Identified a Stromal-Activated Subtype with Poor Survival and Resistance to Immunotherapy in Gastric Cancer.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.868830
- By:
- Publication type:
- Article
High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour‐associated T lymphocyte infiltration.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 8, p. 4452, doi. 10.1111/jcmm.15104
- By:
- Publication type:
- Article
METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 3, p. 1, doi. 10.1007/s00018-022-04129-0
- By:
- Publication type:
- Article
QUantitative and Automatic Atmospheric Correction (QUAAC): Application and Validation.
- Published in:
- Sensors (14248220), 2022, v. 22, n. 9, p. 3280, doi. 10.3390/s22093280
- By:
- Publication type:
- Article
Review of Wireless Personal Communications Radio Propagation Models in High Altitude Mountainous Areas at 2.6 GHz.
- Published in:
- Wireless Personal Communications, 2018, v. 101, n. 2, p. 735, doi. 10.1007/s11277-018-5713-6
- By:
- Publication type:
- Article
Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.
- Published in:
- International Journal of Oncology, 2019, v. 55, n. 5, p. 1049, doi. 10.3892/ijo.2019.4885
- By:
- Publication type:
- Article
Impact of Androgen Receptor Gene Expression in Gastric Cancer: a Meta-Analysis Based on the GEO Database, TCGA Database, and Literature.
- Published in:
- Indian Journal of Surgery, 2022, v. 84, n. 1, p. 28, doi. 10.1007/s12262-020-02168-0
- By:
- Publication type:
- Article
Retraction Note: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02052-z
- By:
- Publication type:
- Article